The slower recovery of RWPE-1_tERG cells after treatment with chemotherapeutic drugs, prompted us to investigate whether the tERG/PIM1 axis could affect genetic stability in early phases of prostate cancer progression. The gene discussed is PIM1; the disease is prostate cancer.